The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development
about
Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.Mechanism of action of a flavin-containing monooxygenaseRevealing the moonlighting role of NADP in the structure of a flavin-containing monooxygenaseEffect of hyperosmotic conditions on flavin-containing monooxygenase activity, protein and mRNA expression in rat kidneyOnpA, an unusual flavin-dependent monooxygenase containing a cytochrome b(5) domain.Predicting the Metabolic Sites by Flavin-Containing Monooxygenase on Drug Molecules Using SVM Classification on Computed Quantum Mechanics and Circular Fingerprints Molecular Descriptors.Pharmacogenetics and diseases of the colon.Osmotic regulation of a novel flavin-containing monooxygenase in primary cultured cells from rainbow trout (Oncorhynchus mykiss).Flavin-containing monooxygenase 3 and human disease.The potential of knockout mouse lines in defining the role of flavin-containing monooxygenases in drug metabolism.Trimethylaminuria: an under-recognised and socially debilitating metabolic disorder.Drug interactions in African herbal remedies.Drug metabolism by flavin-containing monooxygenases of human and mouse.Determinants of the Magnitude of Interaction Between Tacrolimus and Voriconazole/Posaconazole in Solid Organ Recipients.Genetic polymorphisms of flavin monooxygenase 3 in sulindac-induced regression of colorectal adenomas in familial adenomatous polyposis.Fishy Odor and TMA Content Levels in Duck Egg Yolks.Flavin-containing monooxygenase 3 gene polymorphisms in Turkish population.Microbial Flavoprotein Monooxygenases as Mimics of Mammalian Flavin-Containing Monooxygenases for the Enantioselective Preparation of Drug Metabolites.
P2860
Q24539077-59A70FEB-44FC-4327-BCBD-678786A2EEBAQ24550963-FA38A8B5-AAFF-4577-8DC9-0BB68CDFA2DAQ27650474-9F02E465-E090-4AC4-8655-D26ACF23E1B3Q28570562-520EC9C8-B971-4AFA-8483-8E060981087AQ35806062-5E707211-3536-46CA-99B9-EAAABFD9BE02Q36245456-900B01FC-24AE-404A-B639-DF03C4D3489EQ36404764-E6C54709-D7D9-4FE2-A3F7-A678FD319837Q36839694-7187254C-3E08-4799-B3C2-2D9F211D8D4CQ37008890-2AD435E6-B71A-4490-8853-A1D9583B0C36Q37772507-7592EF82-C181-4FF1-9AA1-07FD3E7DF8B7Q37833141-DF3DB650-C3B6-4858-984F-A06A33646B90Q37901060-ED1AF3F4-ACD2-47BF-8E97-B7673B28E1D5Q38966423-7B096EBD-632C-451D-926E-846DE4C4C359Q40322487-24284C7F-F696-4DD0-9318-04097E65D533Q41995896-ED3DE49B-3A3D-4BAA-92F4-8EC5634748DDQ47279263-5111184D-A982-4255-AB0E-7594570DA922Q48031007-C7CADF2F-6440-42E0-9E0B-091027DFB541Q53625601-708D6221-9670-4CAD-8066-E88CE1F039B5
P2860
The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The implications of polymorphi ...... drug discovery and development
@ast
The implications of polymorphi ...... drug discovery and development
@en
The implications of polymorphi ...... drug discovery and development
@nl
type
label
The implications of polymorphi ...... drug discovery and development
@ast
The implications of polymorphi ...... drug discovery and development
@en
The implications of polymorphi ...... drug discovery and development
@nl
prefLabel
The implications of polymorphi ...... drug discovery and development
@ast
The implications of polymorphi ...... drug discovery and development
@en
The implications of polymorphi ...... drug discovery and development
@nl
P1433
P1476
The implications of polymorphi ...... drug discovery and development
@en
P2093
John R Cashman
P304
P356
10.1016/S1359-6446(04)03136-8
P407
P577
2004-07-01T00:00:00Z